임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 예정· Primary Immune Thrombocytopenia (ITP)코르티코스테로이드 치료 실패 소아 원발성 면역혈소판감소증 환자에서 엘트롬보팍에 추가한 이아날루맙 연구
A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.
리드: 노바티스
- 2상모집 예정· DRESS Syndrome약물에 대한 심각한 과민반응(DRESS 증후군)의 치료를 위한 표적치료의 유용성
Interest of a Targeted Therapy for the Treatment of a Severe Form of Hypersensitivity to Drug (DRESS Syndrome)
협력: 아스트라제네카
- 2상모집 예정· Ebola Virus Disease건강한 지원자에서 인마젭 투여와 에르베보 백신 접종 사이의 시간 간격이 백신 면역반응에 미치는 영향
Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers
협력: 리제네론
- 2상모집 예정· Lung Cancer (NSCLC)절제 가능한 고PD-L1 비소세포폐암에 대한 수술 전후 세미플리맙 투여
Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1
협력: 리제네론
- 2상모집 예정· PIK3CA-Related Overgrowth Spectrum (PROS)지속적 투여 및 장기 안전성을 위한 알펠리시브(BYL719) 후속 연구
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
리드: 노바티스
- 2상모집 예정· Central Serous Chorioretinopathy (CSC)만성 중심성 장액성 맥락막망막병증에서의 파리시맙: 무작위 대조 임상시험
Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial
협력: 로슈
- 2상모집 예정· Relapsed /Refractory DLBCLRadiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
협력: 로슈
- 2상모집 예정· Malignant NeoplasmA Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
리드: 머크(MSD)
- 2상모집 예정· Recurrent Adenoid Cystic CarcinomaSacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
협력: 머크(MSD)
- 2상모집 예정· Lymphocytic LeukemiaPhase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD
협력: 로슈
- 2상모집 예정· Obesity or OverweightA Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight
리드: 로슈
- 2상모집 예정· Anal Squamous Cell CarcinomaPhase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell Cancer
협력: 머크(MSD)
- 2상모집 예정· Non-small Cell Lung CancerThe Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2
협력: 아스트라제네카
- 2상모집 예정· Advanced Lung Non-Small Cell CarcinomaSX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
협력: 로슈
- 2상모집 예정· Advanced or Metastatic Solid TumourSCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates
협력: 길리어드
- 2상모집 예정· Chronic Lymphocytic LeukemiaNemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
협력: 머크(MSD)
- 2상모집 예정· Antibody-Mediated Rejection (AMR)A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
리드: 다케다
- 2상모집 예정· Urothelial Bladder CancerEnfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC
협력: 머크(MSD)
- 2상모집 예정· Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 PositiveA Phase 2 Study of ABSK043 Combined With Osimertinib
협력: 아스트라제네카
- 2상모집 중· Generalized Myasthenia GravisA Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
리드: 암젠
- 2상모집 예정· Pulmonary Arterial HypertensionA Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)
리드: 머크(MSD)
- 2상모집 예정· Chronic Immune ThrombocytopeniaStudy of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)
리드: BMS
- 2상모집 예정· Gastrointestinal NeoplasmsA Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib
리드: GSK
- 2상모집 예정· Prostate CancerSacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy
협력: 머크(MSD)
- 2상모집 예정· Chronic Lymphocytic LeukaemiaA Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)
리드: 머크(MSD)
- 2상모집 예정· Locally Advanced Non-Small Cell Lung Cancer (NSCLC)A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
리드: BMS
- 2상모집 예정· Acute Myeloid LeukemiaA Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
협력: 로슈
- 2상모집 중· Colon and Rectal CancerGemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
협력: 리제네론
- 2상모집 중· Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaNemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
협력: 머크(MSD)
- 2상모집 중· Cytokine Release SyndromeInfliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
협력: 얀센(J&J)
- 2상모집 중· Non-small Cell Lung Cancer Stage IIINeoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement
협력: 리제네론
- 2상모집 예정· Colorectal CancerA Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
협력: 아스트라제네카, 일라이 릴리
- 2상모집 예정· Metastatic Castrate Resistant Prostate Cancer (mCRPC)A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy
협력: 화이자
- 2상모집 예정· Multiple Myeloma (MM)A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
협력: 화이자
- 2상모집 예정· Recurrent Mantle Cell LymphomaNemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma
협력: 머크(MSD)
- 2상모집 예정· Immunoglobulin G4-related DiseaseStudy to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD
리드: 암젠
- 2상모집 예정· Overweight or ObesityStudy of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
리드: 리제네론
- 2상모집 예정· Malaria, FalciparumA Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum Malaria
리드: GSK
- 2상모집 중· Carcinoma, Non-Small-Cell LungA Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
리드: 얀센(J&J)
- 2상모집 예정· Crohn's DiseaseA Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
리드: 다케다
- 2상모집 예정· Metabolic Dysfunction-Associated Steatohepatitis (MASH)Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
리드: 리제네론
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.